BreezeBio

South San Francisco, CA · Founded 2016 · Privately Held (backing)

Developer of curative therapies designed for current gene therapy delivery challenges by systematically screening its proprietary nanoparticle library. BreezeBio is based in South San Francisco, CA and was founded in 2016. Its last reported valuation was $234 million in Feb 2026. It has raised $117 million.

Last reported valuation
$234.0M
Oct 2026
Priced at
—
Total raised
$117.0M
Last round
—

Who backs BreezeBio?

39 investors
InvestorType
US National Science FoundationOther
Sequoia CapitalVenture capital
KB InvestmentVenture capital
Korea Investment PartnersVenture capital
Qiming Venture PartnersVenture capital
Korea Development BankOther
University of CaliforniaOther
IMM InvestmentAsset manager
STIC VenturesVenture capital
Kiwoom InvestmentVenture capital
+ 29 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

BreezeBio investors

39 investors are on record for BreezeBio, including US National Science Foundation, Sequoia Capital, KB Investment and Korea Investment Partners. By type, the record holds 12 venture capital firms and 1 hedge fund.

Free account
More of BreezeBio with a free account
  • ·The complete investor list: 39 names
  • ·Watch BreezeBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 39 firms already write checks for companies like BreezeBio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View